Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 417

1.

The direct thrombin inhibitor hirudin.

Greinacher A, Warkentin TE.

Thromb Haemost. 2008 May;99(5):819-29. doi: 10.1160/TH07-11-0693. Review.

PMID:
18449411
2.

Bivalirudin.

Warkentin TE, Greinacher A, Koster A.

Thromb Haemost. 2008 May;99(5):830-9. doi: 10.1160/TH07-10-0644. Review.

PMID:
18449412
3.

Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris.

Hafner G, Rupprecht HJ, Luz M, Terres W, Schindel F, Friesen HJ, Heinrichs H, Jessel A, Meyer J, Prellwitz W.

Eur Heart J. 1996 Aug;17(8):1207-15.

PMID:
8869862
4.

[Use of ecarin clotting time in whole blood for monitoring recombinant hirudine treatment during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia].

Devignes J, de Maistre E, Grosjean S, Walter AF, Hacquard M, Mulot A, Longrois D, Carteaux JP, Lecompte T.

Ann Biol Clin (Paris). 2005 Mar-Apr;63(2):201-8. French.

5.

Cardiovascular drug highlight: hirudin.

Cheng-Lai A.

Heart Dis. 1999 Mar-Apr;1(1):41-9. Review.

PMID:
11720603
6.

Recombinant hirudin is a heparin alternative in cardiac surgery.

Riess FC, Bleese N, Kormann J, Pötzsch B, Madlener K, Müller-Berghaus G, Greinacher A.

J Cardiothorac Vasc Anesth. 1997 Jun;11(4):538-9. No abstract available.

PMID:
9188012
7.
8.

Recombinant hirudin anticoagulation for aortic valve replacement in heparin-induced thrombocytopenia.

Longrois D, de Maistre E, Bischoff N, Dopff C, Meistelman C, Angioï M, Lecompte T.

Can J Anaesth. 2000 Mar;47(3):255-60.

PMID:
10730738
9.

Clinical utility of subcutaneous hirudins.

Deitcher SR.

Am J Health Syst Pharm. 2003 Oct 15;60 Suppl 5:S27-31.

PMID:
14593980
10.

Off-pump coronary artery bypass grafting in a heparin-induced thrombocytopenia type II patient using hirudin.

Carr CS, Rayner A, Ponte J, Desai JB.

Ann Thorac Surg. 2005 Feb;79(2):696-8.

PMID:
15680867
11.

Hirudin in heparin-induced thrombocytopenia.

Lubenow N, Greinacher A.

Semin Thromb Hemost. 2002 Oct;28(5):431-8. Review.

PMID:
12420238
12.

Alternative methods of anticoagulation for dialysis-dependent patients with heparin-induced thrombocytopenia.

O'Shea SI, Ortel TL, Kovalik EC.

Semin Dial. 2003 Jan-Feb;16(1):61-7. Review.

PMID:
12535303
13.

An objective perspective on recombinant hirudin: a new anticoagulant and antithrombotic agent.

Fareed J, Walenga JM, Iyer L, Hoppensteadt D, Pifarre R.

Blood Coagul Fibrinolysis. 1991 Feb;2(1):135-47. Review.

PMID:
1772981
14.
15.
16.

Hirudin for management of heparin-induced thrombocytopenia type II in a patient with biventricular assist device support.

Vogt F, Beiras-Fernandez A, Weis M, Sodian R, Reichart B, Weis F.

Heart Surg Forum. 2009 Dec;12(6):E374-6. doi: 10.1532/HSF98.20091085.

PMID:
20037107
17.

HIT, HITT, and desulfatohirudin: look before you leap.

Edmunds LH Jr.

J Thorac Cardiovasc Surg. 1995 Jul;110(1):1-3. No abstract available.

PMID:
7609532
18.

Current developments in antithrombotic therapy: the role of antithrombin agents.

Breddin HK.

Pathophysiol Haemost Thromb. 2002;32 Suppl 3:1-8. Review.

PMID:
12811005
19.

[R-hirudin (lepirudin, refludan) as an alternative anticoagulant in heparin-induced thrombocytopenia during cardiopulmonary bypass connection].

Shah AC, Genoni M, Niederhäuser U, Maloigne M, Turina M.

Schweiz Med Wochenschr. 2000 Jun 10;130(23):896-9. German.

PMID:
10897491
20.

Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia and thrombosis.

Follis F, Schmidt CA.

Ann Thorac Surg. 2000 Dec;70(6):2173-81. Review.

PMID:
11156153

Supplemental Content

Support Center